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Background The disease burden of influenza-like illnesses (ILIs) on the working population has been docu-
mented in the literature, but statistical evidence of ILI-related work absenteeism in the USA is lim-
ited due to data availability.
Aims To assess work absenteeism due to ILIs among privately insured employees in the USA in 2007–8 
and 2008–9.
Methods We used the 2007–9 MarketScan® research databases. Full-time employees aged 18–64 years, with 
the ability to incur work absence and continuously enroled in the same insurance plan during each 
season were included. We identified ILI episodes using ICD-9 codes for influenza and pneumonia 
(480–487). For each season, we calculated the mean work-loss hours per ILI episode and the pro-
portion of employees who had at least one ILI episode. Work-loss hours and ILI rates were examined 
by subgroups.
Results The mean number of work hours lost per ILI episode was 23.6 in 2007–8 and 23.9 in 2008–9. The 
proportion of employees with at least one ILI was 1.7% in 2007–8 and 1.2% in 2008–9. In both 
seasons, the proportion with ILI was higher among older (2.1 and 1.5%) and hourly workers (2.0 
and 1.3%), workers in the southern region (1.9 and 1.3%) and those in oil, gas or mining industries 
(1.9 and 1.4%).
Conclusions Our results indicate that the disease burden associated with ILIs in the working population is not 
trivial and deserves attention from policymakers and health care professionals to design effective 
strategies to reduce this burden.
Key words  Disease burden; influenza-like illness; work absenteeism.
Introduction
In 2009, influenza and pneumonia were the eighth lead-
ing cause of death in the USA, with around 54 000 asso-
ciated deaths [1]. In 2006, influenza and pneumonia 
were the first-listed diagnosis for around 1300 hospital 
discharges [2]. Although influenza-associated deaths and 
hospitalizations mostly occurred among children and the 
elderly adults [3–7], the disease burden on the working 
population has been well documented in the literature 
[8–11]. However, most of these studies used data from 
European countries, where the mean number of days of 
work lost associated with ILIs was between 0.3 and 5.9 
[11–17]. Few studies have assessed the burden of ILIs 
on US working adults. Kavet [18] used the National 
Health Survey and reported that an average of 3.2 work 
days were lost per ILI case. Using the 1996 Medical 
Expenditure Panel Survey, Akazawa et al. [10] reported 
an average of 1.3 work days missed due to influenza 
(defined as ICD-9 code 487)  among employees aged 
22–64. Nichol et al. [8] surveyed employees aged 50–64 
and reported 1.5 work days lost to ILIs (defined as fever 
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or feeling feverish with cough or sore throat). A North 
Carolina study found that ILIs caused around 1.5 work 
loss days [19]. These studies examined self-reported ILIs 
[8,10,18,19] in a single influenza season [8,10,19], used 
old data [10,18,19] and were geographically limited or 
based on small samples [8,19]. We, therefore, examined 
work hours lost to ILIs in a large sample of full-time pri-
vately insured US employees over two influenza seasons.
Methods
We included in our study population full-time employ-
ees aged 18–64 continuously enroled in the same health 
insurance plan in 2007–8 or 2008–9. We restricted our 
analyses to employees who were eligible to incur work 
absence and who reported work absence hours daily. We 
used the commercial claims and encounters database 
(CCAE) and the health and productivity management 
database (HPM) portion of the MarketScan database for 
2007–9 [20]. The CCAE data track insurance claims (a 
formal request to an insurance company asking for a pay-
ment based on the terms of the insurance policy) from 
providers using a nationwide sample of enrolees who are 
under the age of 65. It collects information from employ-
ers, health plans and state-level Medicaid agencies. The 
subjects include employer-sponsored insured employees 
and their spouses and dependents. The CCAE collects 
information on enrolment records, inpatient, outpatient 
and drug medical claims and associated costs. The ret-
rospective data contain a large proportion of the US 
privately insured population (around 28 million indi-
viduals in 2009). A subset of those enrolled in the CCAE 
is included in the HPM data, which are collected from 
employer payroll systems and contain absence records 
and workers’ compensation records for around 3 mil-
lion employees in 2009. The HPM data allow users to 
determine when employees were absent from work, 
number of absence hours and the reason for the absence. 
MarketScan Database assigns a unique identifier to each 
subject, and thus, medical claims in the CCAE can be 
linked to work absence records in the HPM.
We defined an ILI season as July 1 to June 30 of the 
following year to capture ILIs unrelated to influenza epi-
demics (e.g. pneumonia) [3,5]. We calculated the pro-
portion of employees who had at least one ILI episode in 
2007–8 and 2008–9 and the work-loss hours per ILI epi-
sode. We examined the proportion and work-loss hours by 
age group, gender, metropolitan statistical area (MSA), 
region, industry, employee classification and insurance 
plan type. We determined statistical significances of dif-
ferences within group using two-tailed t-tests. We used 
logistic regression analysis to identify factors associated 
with ILI episodes and linear least squares analysis to 
identify factors related to work-loss hours per episode. 
We used the Stata package (Stata 12; Stata Corporation, 
College Station, TX) for our analyses.
We calculated the mean work-loss hours per ILI epi-
sode as follows: Firstly, we generated a work absence 
file based on the HPM data by combining consecutive 
absence records into one record. For example, if an 
employee had two absences of 8 h on both Friday August 
17 and Monday August 20, they would have only one 
absence record in the work absence file with the starting 
date August 17 and end date August 20 and 16 hours’ 
absence would be recorded.
Secondly, we generated an ILI episode file by extract-
ing ILI-related inpatient and outpatient claims from the 
CCAE. Previous studies have used two influenza-asso-
ciated diagnostic categories to define ILIs: Underlying 
pneumonia and influenza (ICD-9 codes 480–487) and 
underlying respiratory and circulatory conditions (ICD-9 
codes 390–519) [3,5,21]. According to the Centers for 
Disease Control and Prevention (CDC), an ILI case is 
defined as having a fever of at least 37.8°C accompanied 
by cough or sore throat in the absence of a known cause. 
Underlying pneumonia and influenza were more consist-
ent with this definition as many respiratory and circula-
tory conditions do not cause cough or sore throat (e.g. 
heart and cerebrovascular diseases). Thus, we used the 
ICD-9 codes from 480 to 487 to define ILI-related inpa-
tient and outpatient medical encounters. In the CCAE 
data, each observation corresponds to one medical 
encounter. However, one ILI episode may require several 
medical encounters. In order to identify the case start 
and end date of an ILI episode, we used the definition 
in Molinari et  al. [21]: inpatient and outpatient medi-
cal uses incurred 2 weeks before and 4 weeks after the 
inpatient stay were determined as one ILI episode. If an 
employee did not have ILI-related hospitalization during 
the season, ILI-related outpatient visits incurred within 2 
weeks were determined as one ILI episode. Thus, in the 
ILI episode file each ILI episode record had a case start 
and end date, which were the dates the ILI-related medi-
cal encounter was first and last observed in the CCAE, 
respectively.
Finally, we merged the work absence and ILI episode 
files based on the subject’s identification number. Work 
absence was attributable to ILIs if the absence start and 
end dates were within 5 days of the employee’s ILI epi-
sode duration.
We conducted sensitivity analyses by including both 
full-time and part-time workers to evaluate the potential 
impact of part-time workers on work loss. We also rede-
fined the influenza season as September 1 to March 31 
of the following year to examine whether outcomes were 
sensitive to the definition of ILI season. Although our 
length of an ILI episode was based on study by Molinari 
et al. [21], a consensus of the length was not available in 
the literature. According to the CDC seasonal influenza 
information [22], infectivity generally lasts 5–7 days after 
becoming sick [22]. We, therefore, used 7  days dura-
tion to define an ILI episode for the sensitivity analysis. 
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We pooled the 2007–8 and 2008–9 data to perform a 
multivariate logistic regression analysis on whether an 
employee had at least one ILI episode during the applic- 
able season. We performed a linear regression analysis on 
work-loss hours per ILI episode in 2007–8 and 2008–9.
This study was reviewed by the Human Subjects 
Coordinator at CDC’s National Center for Immunization 
and Respiratory Diseases. As an analysis of secondary 
data without identifiers, this study was deemed not to 
require ethical approval.
Results
Our analysis included 186 056 and 195 366 employees in 
2007–8 and 2008–9, respectively. Characteristics of the study 
population were similar (Table 1). We identified 2406 ILI-
related work absence records in 2007–8 and 1675 in 2008–9. 
ILI-related work absenteeism peaked in February during 
both seasons. The mean work-loss hours per ILI were 23.6 
in 2007–8 and 23.9 in 2008–9 (Table 2). Work-loss hours per 
episode were greater if the ILI episode was associated with 
hospitalization: 47.0 in 2007–8 and 46.1 in 2008–9. The 
mean length of hospital stay was 4.4 days in 2007–8 and 4.9 
in 2008-9. In both seasons, workers in the oldest age group 
had the most work-loss hours: 25.2 in 2007–8 and 24.1 in 
2008–9 (Table 3).
Table  4 shows the proportion of employees having 
at least one ILI: 1.7% of 186 056 employees in 2007–8 
and 1.2% of 195 366 in 2008–9. The proportion having a 
single ILI episode in the first season was 1.6 and 0.2% 
had at least two episodes. The corresponding numbers 
for 2008–9 were 1.0 and 0.1%. Employees in the oldest 
age group had the highest proportion of ILI-related med-
ical encounters (2.1%, P < 0.001, in 2007–8 and 1.5%, 
P < 0.001, in 2008–9). In both seasons, the proportion 
was higher among employees residing in the southern 
region (1.9 and 1.3%), employees working in the oil, gas 
or mining industries (1.9 and 1.4%) and hourly workers 
(2.0 and 1.3%).
The inclusion of part-time workers did not change 
our results noticeably. In 2007–8, ILI-related work-loss 
hours per episode were 23.6 and 1.2% of 187 089 work-
ers had at least one ILI. The corresponding numbers in 
2008–9 were 22.7 and 1.2% (of 196 388 employees). 
Results were similar as we redefined the influenza season. 
Proportions of employees with ILIs did not change if we 
used a 7-day duration to define an ILI episode. Work-loss 
hours associated with ILIs were slightly lower, at 21.7 
and 22.2 in 2007–8 and 2008–9, respectively.
Controlling for age group, gender, MSA, region, 
industry, employee classification and type of insurance 
plan, the odds of having an ILI were lower in 2008–9 
(odds ratio (OR  =  0.7, P  <  0.01) compared with the 
2007–8 season. The odds of having an ILI were higher 
among employees in the oldest age group (OR = 1.5, 
P  <  0.01) and hourly workers (OR  =  1.3, P  <  0.01) 
compared with the reference groups. Compared with 
employees in the southern region, the odds of having an 
ILI were significantly lower among workers located in 
other regions.
Age, region and industry were significantly associated 
with ILI-related work-loss hours. Workers aged 55–64 
had 3.1 (P < 0.001) more ILI-related absence hours than 
workers in the 18–34 age group. Employees in the north-
east region had fewer ILI-related work-loss hours (−3.5 h, 
P  <  0.001) than employees in the southern region. 
Table 1. Characteristics of the study population by influenza 
season
2007–8, 
N = 186 056 
n (%)
2008–9,  
N = 195 366 
n (%)
Age group
 18–34 37 345 (20) 42 135 (22)
 35–44 46 652 (25) 45 857 (23)
 45–54 72 838 (39) 75 703 (39)
 55–64 29 221 (16) 31 671 (16)
Sex
 Male 130 914 (70) 136 780 (70)
 Female 55 142 (30) 58 586 (30)
MSA (metropolitan statistical area)
 Yes 179 327 (96) 188 245 (96)
 No 6729 (4) 7121 (4)
Regiona
 Northeast 17 681 (10) 18 430 (9)
 North central 34 687 (19) 37 109 (19)
 South 42 979 (23) 45 187 (23)
 West 90 709 (49) 94 640 (48)
Industry
 Oil and gas extraction, 
mining
24 264 (13) 24 235 (12)
 Manufacturing, durable 127 638 (69) 134 045 (69)
 Manufacturing, 
non-durable
21 961 (12) 23 800 (12)
 Services 12 193 (7) 13 286 (7)
Employee classification
 Salaried 130 975 (70) 135 024 (69)
 Hourly 55 057 (30) 59 318 (30)
 Unknown 24 (0) 1024 (1)
Plan type
 FFS 1025 (1) 993 (1)
 HMO 41 749 (22) 43 721 (22)
 Non-capitated POS 18 526 (10) 11 839 (6)
 PPO 124 756 (67) 138 813 (71)
Influenza seasons were defined as July 1 through June 30 of the following year. 
FFS: fee for service; HMO: health maintenance organization; Non-capitated 
POS: non-capitated point of service; PPO: preferred provider organization.
aNortheast region includes Maine, New Hampshire, Vermont, Massachusetts, 
Rhode Island, Connecticut, New York, Pennsylvania and New Jersey. North 
central region includes Wisconsin, Michigan, Illinois, Indiana, Ohio, Missouri, 
North Dakota, South Dakota, Nebraska, Kansas, Minnesota and Iowa. 
South region includes Delaware, Maryland, District of Columbia, Virginia, 
West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, 
Tennessee, Mississippi, Alabama, Oklahoma, Texas, Arkansas and Louisiana. 
West region includes Idaho, Montana, Wyoming, Nevada, Utah, Colorado, 
Arizona, New Mexico, Alaska, Washington, Oregon, California and Hawaii.
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Table 2. Work hours lost per ILI episode by influenza season
ILI episodes (n) Work-loss hours
Mean P value 95% confidence intervals
2007–8 2406 23.6 NS 22.9 24.4
2008–9 1675 23.9 23.0 24.8
Work-loss hours associated with only outpatient visits
2007–8 2295 22.5 NS 21.9 23.2
2008–9 1579 22.5 21.7 23.4
Work-loss hours associated with hospitalization
2007–8 111 47.0 NS 39.8 54.2
2008–9 96 46.1 39.0 53.1
ILI-related hospitalization, Length of stay
2007–8 111 4.4 NS 3.5 5.2
2008–9 96 4.9 4.0 5.8
Influenza seasons were defined as July 1 to June 30 of the following year. An ILI episode was defined using the ICD-9 codes 480–487.
Table 3. Work hours lost per ILI episode by influenza season and employee characteristics
2007–8, n = 2406 P value 2008–9, n = 1675 P value
Age group <0.05 <0.01
 18–34 21.6 21.4
 35–44 23.5 22.4
 45–54 23.8 25.7
 55–64 25.2 24.1
Sex NS NS
 Male 23.7 24.1
 Female 23.6 23.5
MSA <0.05 NS
 Yes 23.5 23.9
 No 27.0 23.1
Regiona <0.01 NS
 Northeast 19.0 20.5
 North central 23.9 22.7
 South 24.5 24.5
 West 23.7 24.4
Industry <0.05 <0.05
 Oil and gas extraction, mining 25.9 26.1
 Manufacturing, durable 23.5 23.7
 Manufacturing, non-durable 21.1 20.6
 Services 23.4 26.6
Employee classification NS NS
 Salaried 23.9 23.7
 Hourly 23.2 24.3
 Unknown —
Plan type NS NS
 FFS 18.6 26.6
 HMO 24.1 23.8
 Non-capitated POS 23.3 26.5
 PPO 23.6 23.6
Influenza seasons were defined as July 1 to June 30 of the following year. FFS: fee for service; HMO: health maintenance organization; Non-capitated POS: non-
capitated point of service; PPO: preferred provider organization.
aNortheast region includes Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, Pennsylvania and New Jersey. North central 
region includes Wisconsin, Michigan, Illinois, Indiana, Ohio, Missouri, North Dakota, South Dakota, Nebraska, Kansas, Minnesota and Iowa. South region includes 
Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Mississippi, Alabama, 
Oklahoma, Texas, Arkansas and Louisiana. West region includes Idaho, Montana, Wyoming, Nevada, Utah, Colorado, Arizona, New Mexico, Alaska, Washington, 
Oregon, California and Hawaii.
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ILI-related work-loss hours were lower (around −3 h, 
P < 0.05) among workers in manufacturing industry com-
pared with workers in the oil, gas or mining industries.
Discussion
We found that the mean work hours lost per ILI episode 
were 23.6 and 23.9 in 2007–8 and 2008–9, respectively. 
The proportion of employees having at least one ILI 
episode was 1.7% in 2007–8 and 1.2% in 2008–9. The 
prevalence of ILIs was higher among older and hourly 
workers, those in the southern region and those in oil, 
gas or mining industries. To our knowledge, this is the 
first study to use insurance claims data to analyze work 
absences associated with ILIs in the USA. Our data 
sources cover a large proportion of the privately insured 
population and allowed analyses of two influenza sea-
sons. Our findings provide an updated evaluation of the 
disease burden of ILIs in the US working population. By 
considering medically attended and physician-diagnosed 
ILIs, this study offers a different perspective from previ-
ous studies in the USA using self-reported data.
Our findings should be interpreted in the light of some 
study limitations. Firstly, considering medically attended 
ILIs may underestimate the proportion of workers with 
ILIs and may overestimate work-loss hours per ILI as 
medically attended ILIs will generally be more severe 
cases. However, our number of work-loss hours was con-
sistent with studies using physician-diagnosed ILIs (an 
average of 3.7–5.9 work-loss days) [12,15,23], and our 
Table 4. Proportion of employees having ILI by influenza season and employee characteristics
2007–8, n = 186 056 2008–9, n = 195 366
n (%) P value n (%) P value
Full 3198 (1.7) 2304 (1.2)
Age group <0.001 <0.001
 18–34 555 (1.5) 384 (0.9)
 35–44 792 (1.7) 521 (1.1)
 45–54 1235 (1.7) 917 (1.2)
 55–64 616 (2.1) 482 (1.5)
Sex NS NS
 Male 2266 (1.7) 1594 (1.2)
 Female 932 (1.7) 710 (1.2)
MSA <0.05 NS
 Yes 3058 (1.7) 2219 (1.2)
 No 140 (2.1) 85 (1.2)
Regiona <0.001 <0.001
 Northeast 243 (1.4) 206 (1.1)
 North central 606 (1.8) 340 (0.9)
 South 835 (1.9) 587 (1.3)
 West 1514 (1.7) 1171 (1.2)
Industry <0.001 <0.01
 Oil and gas extraction, mining 469 (1.9) 332 (1.4)
 Manufacturing, durable 2216 (1.7) 1597 (1.2)
 Manufacturing, non-durable 317 (1.4) 247 (1.0)
 Services 196 (1.6) 128 (1.0)
Employee classification <0.001 <0.001
 Salaried 2090 (1.6) 1503 (1.1)
 Hourly 1108 (2.0) 794 (1.3)
 Unknown 0 (0) 7 (0.7)
Plan type NS <0.01
 FFS 11 (1.1) 6 (0.6)
 HMO 746 (1.8) 502 (1.2)
 Non-capitated POS 321 (1.7) 174 (1.5)
 PPO 2120 (1.7) 1622 (1.2)
Influenza seasons were defined as July 1 through June 30 of the following year. FFS: fee for service; HMO: health maintenance organization; Non-capitated POS: non-
capitated point of service; PPO: preferred provider organization.
aNortheast region includes Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, Pennsylvania and New Jersey. North central 
region includes Wisconsin, Michigan, Illinois, Indiana, Ohio, Missouri, North Dakota, South Dakota, Nebraska, Kansas, Minnesota and Iowa. South region includes 
Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Mississippi, Alabama, 
Oklahoma, Texas, Arkansas and Louisiana. West region includes Idaho, Montana, Wyoming, Nevada, Utah, Colorado, Arizona, New Mexico, Alaska, Washington, 
Oregon, California and Hawaii.
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rate of ILIs was consistent with Fowlkes et al. [24], which 
used influenza surveillance data covering six states during 
the 2009–10 season (the cumulative ILI incidence among 
adults was 13 per 1000 population). Secondly, our ILIs 
were not laboratory confirmed. However, they were phy-
sician diagnosed and were consistent with the seasonal 
pattern of ILIs reported by CDC [23]: The number of 
influenza cases was greater in 2007–8 than in 2008–9 
and case numbers peaked in February in both seasons. 
Regional outpatient illness and viral surveillance data [25] 
also indicated that the number of influenza positive tests 
was considerably higher in the southern region in both 
seasons. Thus, we believe that our analysis represents an 
acceptably accurate measure of the burden of ILIs on US 
working adults. Finally, the MarketScan data are collected 
from large self-insured employers, and therefore, indus-
tries that primarily consist of part-time or self-employed 
workers (e.g. construction, retail, agriculture, forestry 
and fishing) may be under-represented. Moreover, our 
analyses included workers with the ability to incur work 
absence and who were continuously enroled in a private 
insurance plan, which limits their applicability to the wider 
US working population. However, this study evaluated the 
disease burden in a large part of the working population as 
around 85% of full-time workers aged 18–64 in 2009 were 
covered by private health insurance [26].
The 2008–9 season included the start of the H1N1 
influenza pandemic (April 2009), which may have 
affected the reporting of ILIs in 2009 compared with the 
previous season. However, according to CDC, influenza 
activity peaked in October 2009 (after our 2008–9 sea-
son) and had a greater impact on children and young 
adults. Moreover, according to the US Outpatient Illness 
Surveillance, during the initial wave of the H1N1 pan-
demic, the percentage of ILI outpatient visits was around 
the national baseline level, exceeding the baseline level 
in August 2009 after our 2008–9 season. Also our sen-
sitivity analysis redefined the season as September 1 to 
March 31 of the following year with very similar results. 
Therefore, we believe that the H1N1 pandemic had a 
modest impact on our analyses.
Consistent with previous studies [4,5], we found that 
employees in the oldest age group were most vulnerable 
to ILIs. This may be due to their higher propensity to 
seek medical care because of co-morbidities, since our 
identified ILIs were all medically attended. Assuming an 
8-h work day, our study indicated that employees lost 
around 3  days of work per ILI episode. This number 
was similar to Kavet [18] but greater than in other US 
studies. The observed differences may be due to differ-
ences in study design, inclusion criteria, the definition of 
ILIs and the severity of ILIs during the study years. Also 
ILIs and work-loss days were self-reported in previous 
studies, whereas ours were based on insurance claims in 
which ILIs were medically attended and physician diag-
nosed. Studies estimating the rate of ILIs in the working 
population are limited, but our rate of ILIs was consider-
ably lower than in previous studies. Including medically 
attended ILIs may underestimate the occurrence rate. 
Studies with small sample sizes tended to have a high 
occurrence rate of ILIs [9,27–29].
We found no existing studies of ILI-related work 
absenteeism or influenza vaccine coverage by industry 
or employee classification. Variations in ILI-attributable 
work absence by industry and employee classification may 
reflect variations in access to care, differences in work ben-
efits (as workplace influenza vaccines are more likely to be 
available for salaried workers) and differences in regional 
influenza circulation intensity, as 88% of employees in the 
oil, gas extraction or mining industries in our study popu-
lation were located in the southern region.
Previous studies have reported 9 work days lost annu-
ally for workers with depressive disorders, around 3 days 
per month for asthma and 4 days per month for arthritis, 
diabetes or high blood pressure [30]. Employed adults 
over 18 lost an average of 4 work days due to illness or 
injury in the past year (2007 National Health Interview 
Survey, NHIS). Although difficult to compare directly to 
sickness absence data from other conditions, the disease 
burden associated with ILIs in the US working popu-
lation is not trivial and deserves attention from policy-
makers and health care professionals to design effective 
strategies to reduce the burden.
Immunization against influenza has proved to be 
effective in preventing influenza. However, only 28% of 
US adults aged 18–64 received an influenza vaccination 
in the 2008–9 season (2009 NHIS). It is unclear whether 
increasing vaccination coverage among working adults 
would reduce the impact of ILIs on sickness absence. At 
present the only occupational group to which influenza 
vaccination is usually offered are health care workers. 
Providing vaccination in other workplaces and extend-
ing the vaccination benefit to part-time workers may 
effectively reduce the transmission of influenza among 
co-workers and associated work loss. In light of our find-
ings of the variations in ILI-attributable work absence 
by industry and region, efforts to reduce ILIs could be 
targeted at specific regions or occupations.
Key points
 • This study found that US workers lost approxi-
mately 3 days of work per influenza-like illness epi-
sode in 2007–9.
 • The proportion having influenza-like illnesses was 
higher among older or hourly workers and workers 
in the southern USA and in the oil, gas or mining 
industries.
 • Measures to reduce the burden of influenza-like 
illnesses in the US workforce should be, therefore, 
considered.
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